<DOC>
	<DOCNO>NCT00935168</DOCNO>
	<brief_summary>The aim study determine whether patient Intensive Care Unit receive fluid resuscitation either hydroxyethyl starch ( synthetic colloid solution ) saline ( salt solution ) , increased rate survival 90 day .</brief_summary>
	<brief_title>Crystalloid Versus Hydroxyethyl Starch Trials</brief_title>
	<detailed_description>Patients intensive care unit frequently require intravenous fluid treat clinician consider patient 's blood pressure circulate blood volume need increase clinically acceptable level . Despite fluid resuscitation fundamental part standard medical treatment critically ill patient , clinician leave uncertainty optimal choice volume fluid administer . This study prospective , multi−centre , blind , randomise control trial . The two fluid compare 0.9 % sodium chloride ( saline ) 6 % hydroxyethyl starch 130/0.4 0.9 % sodium chloride , ( starch ) . The null hypothesis assume difference all-cause mortality patient give starch comparison patient give saline fluid resuscitation . Each patient meet inclusion criterion none exclusion criterion randomise receive one two study fluid fluid resuscitation . Once treatment assign participant continue receive either starch saline fluid resuscitation requirement intensive care . The treat clinical team decide amount frequency fluid give resuscitation base standard care . During ICU stay , participant information use study fluid , fluid , kidney function , blood pressure , heart rate haemodynamic data routinely record medical record collect . All participant follow day 90 6 month randomisation . The participant status ( alive , hospital length stay ) record day 28 day 90 randomisation . At 6 month follow−up participant carer interview telephone use standardised questionnaire participant 's quality life . In addition , participant admit intensive care traumatic brain injury interview determine well participant recover . After patient complete 6 month follow−up , data linkage also use link patient ( NSW ) health database order obtain information use health service .</detailed_description>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Written inform consent obtain possible , procedure obtain informed consent approve ethic committee . Fluid resuscitation require increase maintain intravascular volume addition maintenance fluid , enteral parenteral nutrition , blood product specific replacement fluid replace ongoing insensible fluid loss site ( e.g. , fistula loss gastrointestinal tract , urinary loss diabetes insipidus polyuric phase acute renal failure correct metabolic derangement ) . The ICU clinician considers 6 % hydroxyethyl starch ( 130/0.4 ) saline equally appropriate patient specific indication contraindication either exists . The requirement fluid resuscitation must support AT LEAST ONE follow clinical sign : 1 . Heart rate &gt; 90 beat per minute 2 . Systolic blood pressure ( SBP ) &lt; 100mmHg mean arterial pressure ( MAP ) &lt; 75mmHg least 40mmHg decrease SBP MAP baseline record 3 . Central venous pressure &lt; 10mmHg 4 . Pulmonary artery wedge pressure &lt; 12 mmHg 5 . Respiratory variation systolic mean arterial blood pressure &gt; 5 mmHg 6 . Capillary refill time &gt; one second 7 . Urine output &lt; 0.5 ml/kg one hour Previous allergic reaction hydroxyethyl starch solution . Primary nontraumatic intracranial haemorrhage severe traumatic intracranial haemorrhage ( mass lesion &gt; 25 ml ) . Patients receive renal replacement therapy ICU physician considers renal replacement therapy imminent ( i.e . renal replacement therapy start 6 hour ) Patients document serum creatinine value ≥ 350µmol/L urine output average ≤ 10ml / hr 12 hour Severe hypernatraemia ( Serum sodium &gt; 160 mmol/l ) severe hyperchloraemia ( Serum chloride &gt; 130 mmol/l ) . Women child bear age ( 1849 year old ) , unless evidence document menopause , hysterectomy surgical sterilisation negative pregnancy test randomisation Breastfeeding Patients receive &gt; 1000mL hydroxyethyl starch 24 hour randomization . Patients admit ICU follow cardiac surgery ; patient admit ICU follow cardiac surgery . Patients admit ICU treatment burn follow liver transplantation surgery . Death deem imminent inevitable patient underlie disease process life expectancy &lt; 90 day . A limitation therapy order document restrict implementation study protocol treat clinician deems aggressive care unsuitable . Patient previously enrol CHEST study . Patient previously receive fluid resuscitation prescribe within study ICU current ICU admission . Patient transfer study ICU another ICU receive fluid resuscitation treatment volume depletion ICU .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Intensive Care</keyword>
	<keyword>Fluid Resuscitation</keyword>
	<keyword>Saline</keyword>
	<keyword>Hydroxy-ethyl starch</keyword>
</DOC>